Your session is about to expire
← Back to Search
Behavioral Intervention
Enhanced Anxiety Treatment for Anxiety Disorders
N/A
Waitlist Available
Led By Nicholas Allan, PhD
Research Sponsored by Canandaigua VA Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants will include men and women Veterans who score ≥ 5 on the WHODAS 2.0
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediately post-intervention, one month post-intervention, three month post-intervention
Awards & highlights
Study Summary
This trial will test a new treatment to reduce anxiety sensitivity and functional impairment in Veterans.
Who is the study for?
This trial is for Veterans over 18 with heightened anxiety sensitivity and some daily life impairment. They must speak English, have a smartphone, and score above certain thresholds on specific tests measuring anxiety and functioning. Those with severe cognitive impairments or psychiatric conditions like active psychosis or high suicide risk are excluded.Check my eligibility
What is being tested?
The study is evaluating the Brief Enhanced Anxiety Sensitivity Treatment (BEAST) to see if it's suitable, doable, and user-friendly for reducing anxiety sensitivity and improving how well Veterans function in their daily lives.See study design
What are the potential side effects?
Since this is a psychological treatment focused on managing anxiety sensitivity rather than a drug intervention, typical medical side effects are not expected. Participants may experience discomfort discussing personal experiences related to anxiety.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a veteran with a disability score of 5 or higher.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ daily, from baseline to post-intervention for a total of two weeks, then for one week following one month follow-up and three month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily, from baseline to post-intervention for a total of two weeks, then for one week following one month follow-up and three month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Anxiety Sensitivity Index-3 (ASI-3) - assessing change throughout the study
Program Satisfaction Questionnaire (PSQ)
WHO Disability Assessment 2.0 (WHODAS 2.0) - assessing change throughout the study
Secondary outcome measures
Anxiety, Depression, Distress Inventory-27 (ADDI-27) - assessing change throughout the study
Brief Penn State Worry Questionnaire - PSWQ - assessing change throughout the study
Coronavirus Impact Battery - Behavior Scales - assessing change throughout the study
+3 moreOther outcome measures
Blessed Orientation Memory Concentration Test (BOMC)
Depression Symptom Index Suicidality Scale (DSI-SS) - assessing change throughout the study
Intolerance of Uncertainty-12 (IUS-12) - assessing change throughout the study
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: BEAST InterventionExperimental Treatment1 Intervention
A one-session intervention that can be delivered effectively by a clinician via telehealth and supplemented with a mobile app to provide opportunities to practice the skills learned in the face-to-face session.
Find a Location
Who is running the clinical trial?
Canandaigua VA Medical CenterLead Sponsor
12 Previous Clinical Trials
1,831 Total Patients Enrolled
VA Office of Research and DevelopmentFED
1,609 Previous Clinical Trials
3,306,588 Total Patients Enrolled
1 Trials studying Anxiety Sensitivity
15 Patients Enrolled for Anxiety Sensitivity
Nicholas Allan, PhDPrincipal InvestigatorVA Fingerlakes Healthcare System
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a Veteran and I speak English.I am a veteran with a disability score of 5 or higher.I do not have severe mental health issues that could interfere with study participation.I am a Veteran aged 18 or older.I am a veteran with an anxiety sensitivity score of 9 or higher.
Research Study Groups:
This trial has the following groups:- Group 1: BEAST Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the end objective of this research endeavor?
"The purpose of this trial, which will be monitored at Baseline, directly after intervention, one month post-intervention and three months post-intervention is to assess the Program Satisfaction Questionnaire (PSQ). Secondary endpoints include Functional Impairment Due to COVID (FIDC), PROMIS Profile-29 and Brief Penn State Worry Questionnaire - PSWQ. The FIDCO rate ranges from 0 for no difficulty in functioning up to 4 for very high difficulty; the PROMIS score varies between 1 with no distress or experience up to 5 that indicate intense suffering; while the PSWQ evaluates"
Answered by AI
Are there any current vacancies in this clinical trial?
"Data provided by clinicaltrials.gov show that this particular medical trial is not presently looking for participants, having been initially posted on October 1st 2022 and modified most recently on August 3rd 2022. However, 667 other studies are actively recruiting candidates at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger